rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Incannex Healthcare Inc.

IXHL · Nasdaq

Health CareBiotechnologyNot moving yet

IXHL stood above a rising 150-day average in 1 of the last 52 weekly readings, and has been out of that trend for the last 43 weeks. It is 17.6% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 43
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
16 (-3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 1 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders16-3 on the quarter
New · exited7 · 10
Reported value$1.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
LPL Financial LLCadded · filed 7 Aug 2026148,178$557K+77,000+108.2%
MILLENNIUM MANAGEMENT LLCnew · filed 14 Aug 202695,252$358K+95,252
JANE STREET GROUP, LLCnew · filed 14 Aug 202678,195$294K+78,195
AdvisorShares Investments LLCadded · filed 11 Aug 202660,868$229K+36,365+148.4%
SUSQUEHANNA INTERNATIONAL GROUP, LLPnew · filed 14 Aug 202628,771$108K+28,771
COMMONWEALTH EQUITY SERVICES, LLCadded · filed 29 Jul 202614,029$53K+1,917+15.8%
CITADEL ADVISORS LLCnew · filed 14 Aug 202610,349$39K+10,349
OSAIC HOLDINGS, INC.unchanged · filed 14 Aug 20266,376$24K00.0%
UBS Group AGreduced · filed 13 Aug 20263,610$14K-36,759−91.1%
MORGAN STANLEYadded · filed 13 Aug 20263,558$13K+1,493+72.3%
31 Mar 2023 – 30 Jun 2026
31424Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

George Anastassov Company insiderDirector · last 14 Nov 20250 · 0
Joel Latham Company insiderCEO and President · last 14 Nov 20250 · 0
Joseph Swan Company insiderCFO, Treasurer and Secretary · last 14 Nov 20250 · 0
Peter Widdows Company insiderDirector · last 14 Nov 20250 · 0
Robert Clark Company insiderDirector · last 14 Nov 20250 · 0
Troy Valentine Company insiderDirector · last 14 Nov 20250 · 0
Luigi M. Barbato Company insiderChief Medical Officer · last 23 Oct 20240 · 0

Same industry

MRNA ModernaLeading+147%
IOVA Iovance BiotherapeuticsLeading+126%
ABCL AbCellera BiologicsLeading+60%
HALO Halozyme TherapeuticsLeading+46%
XERS Xeris Biopharma HoldingsLeading+38%
ENTX Entera BioLeading+37%
HELP Helus PharmaLeading+36%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2026 · to 30 Jun 2026-32.2%
Share count trendFY 2026 · to 24 Sep 20260.0%
Cash and equivalentsFY 2026 · to 30 Jun 2026$67.7M
Free cash flowFY 2026 · to 30 Jun 2026−$12.9M

Analyst forecasts

No analyst forecasts yet.